{
    "2020-10-03": [
        [
            {
                "time": "2023-10-01",
                "original_text": "【国信医药】魔鬼在细节：三张表中的投资机会（医药分析框架系列报告2）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "投资机会",
                        "医药分析",
                        "三张表"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "魔鬼在细节：三张表中的投资机会",
                "features": {
                    "keywords": [
                        "魔鬼在细节",
                        "三张表",
                        "投资机会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}